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Background: Tobacco smoking and alcohol drinking generate oxidative DNA damage and may contribute to larynx carcinogenesis. 
The X-ray repair cross complementing 1 (XRCC1) and excision repair cross-complementing rodent repair deficiency, complementa-
tion group 4 (ERCC4(XPF)) genes are important components of DNA excision repair systems, which repair DNA damage induced 
by various factors, including tobacco smoking and alcohol. Aim: To investigate the association between the genotypes of the XRCC1-
Arg399Gln (rs25487) and ERCC4-Arg415Gln (rs1800067) polymorphisms and smoking- and drinking-related larynx cancer in a Polish 
population. Methods: The polymorphisms were determined by PCR-RFLP method in 253 patients with squamous cell carcinoma of the 
larynx and 253 sex- and age-matched controls. Results: We did not find any association between the investigated polymorphisms and 
larynx carcinoma, dependent on either smoking or drinking status. No association was found between these polymorphisms and larynx 
cancer grade, stage or age at diagnosis. Conclusions: The results indicated that Arg399Gln polymorphism of XRCC1 gene and Arg-
415Gln polymorphism of ERCC4 gene may not be associated with smoking- and drinking-related larynx cancer in Polish population.
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Tobacco smoking and alco�ol exposure are well 
known risk factors in t�e development of squamous cell 
carcinoma of t�e larynx. It was suggested t�at single 
nucleotide polymorp�isms �SNPs� in t�e DNA repair 
genes may alter t�e ability of cells to repair damaged 
DNA� and initiate malignant transformation. X-ray repair 
cross-complementing � �XRCC1� gene coding for t�e 
XRCC�� one of a key protein of base excision repair �BER� 
pat�way. Excision repair cross-complementing rodent 
repair deficiency� complementation group 4 �ERCC4/
XPF) gene coding for t�e ERCC4/XPF protein one of es-
sential parts of nucleotide excision repair �NER� pat�way. 
A G → A substitution at �8��� of t�e XRCC1 gene� exon 
��� producing an Arg to Gln c�ange in codon �99 �t�e 
Arg�99Gln polymorp�ism� �as been linked to slig�tly 
�marginally statistically significant� increased risk of la-
ryngeal carcinoma among Caucasians [�]. T�e ERCC4/
XPF G��44A polymorp�ism is a G-to-A c�ange in t�e 
exon 8 �Arg4��Gln� rs�8����7� t�at results in a c�ange 
from arginine to glutamine at 4�� codon. T�is polymor-
p�ism �as been reported to be associated wit� an in-
creased risk for breast cancer [�].
In t�is paper� we �ave used a �ospital-based case-
control study in Poland to assess t�e potential association 
of t�e XRCC1-Arg�99Gln and ERCC4-Arg4��Gln SNPs 
wit� t�e development and clinical pat�ological parameters 
of larynx cancer.
Patients. Blood samples were obtained from ��� pa-
tients: �94 men and �9 women wit� larynx cancer �squa-
mous cell carcinoma� treated in t�e Department of Head 
and Neck Cancer� �edical University of Lodz� Lodz� 
Poland and Department of Otolaryngology� �edical 
University of Poznan� Poznan� Poland in ��������9 and 
��� cancer-free age and sex matc�ed controls. T�e 
patients ranged in age from 48 to 8� years �median age 
�� years�. Grade of differentiation �G� was evaluated in all 
cases �according to World Healt� Organization criteria�. 
T�ere were ��8 cases of � grade� ��4 cases of  � grade 
and �� of � grade in total. According to TN� staging t�ere 
were �� cases of stage I� �� cases of stage II� ��� cases 
of stage III� 4� cases of stage IVA and � of stage IVB. T�e 
study was approved by Et�ic Committee of �edical 
University of Lodz and �edical University of Poznan� and 
eac� patient gave a written consent.
DNA isolation. Perip�eral blood lymp�ocytes 
�PBLs� were isolated by centrifugation in a density 
gradient of Histopaque-��77 ��� min� �8�g�. T�e pellet 
containing PBLs was resuspended in Tris-EDTA buffer� 
pH 8� to give about ��� x��� cells/ml. Genomic DNA 
was extracted from PBLs by p�enol/c�loroform extrac-
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tion and proteinase K digestion. T�e final samples were 
kept in Tris-EDTA buffer� pH 8� at ���  °C until use.
Genotype determination. T�e PCR — restriction 
fragment lengt� polymorp�ism met�od �PCR � RFLP� 
was used to detect t�e genotypes of t�e Arg�99Gln 
polymorp�ism of XRCC1 gene and t�e Arg4��Gln poly-
morp�ism of ERCC4 gene as described previously [�� 4]. 
Data analysis. For eac� genotype� deviation of t�e 
frequencies in t�e controls from t�ose expected under 
Hardy — Weinberg equilibrium was assessed using t�e 
standard χ�-test. Genotype frequencies in cases and 
controls were compared by χ�  or Fis�er’s exact tests. 
T�e genotype-specific risks were estimated as odds 
ratios �ORs� by unconditional logistic regression. Wild 
type Arg/Arg genotype was used as t�e reference. 
Because of small number of Gln/Gln variant genotypes 
of bot� polymorp�isms odds ratios were calculated 
for Gln allele carriers �Arg/Gln + Gln/Gln genotypes� 
p-values < �.�� were considered to be significant.
All statistical analyses were performed wit� Sigma-
Stat� ver. 8.� �Systat Software Inc� San Jose� CA� USA�.
We s�owed previously t�at �eavy alco�ol drinking and 
tobacco smoking increased significantly t�e risk of laryn-
geal carcinoma independently of any genetic variation 
�OR = �8; p < �.���� for smoking and drinking �eavily� 
[�]. Tobacco smoke contains many kinds of carcinogens 
t�at can cause DNA lesions� and variations in repair of to-
bacco carcinogen-induced DNA lesions may contribute 
to t�e variation in susceptibility to cancer [�]. 
It was suggested t�at SNP at codon �99 of t�e 
XRCC1 gene may alter t�e ability of XRCC1 to repair 
damaged DNA [7]. It was also s�own t�at t�e �99Gln �o-
mozygote genotype was associated wit� increased levels 
of bulky-DNA adducts in leucocytes of non-smokers [8].
From t�e PCR analysis� ��� larynx cancer patients 
and ��� controls were divided into t�ree genotypes: 
Arg/Arg� Arg/Gln and Gln/Gln for bot� gene polymor-
p�isms. Distributions of genotypes did not differ sig-
nificantly from t�ose predicted by t�e Hardy-Weinberg 
equilibrium. T�ere were no significant differences 
in t�e frequencies of bot� polymorp�isms genotypes 
between patients and controls �p > �.���. Additionally� 
odds ratio analysis did not s�ow any relation between 
t�is polymorp�isms and larynx cancer �data not s�own�.
All ��� larynx cancer cases were stratified by grade 
of differentiation and stage of disease. Grades � and 
� were grouped toget�er for t�e purposes of statistical 
analysis. T�ere were no significant differences between 
distributions of genotypes in subgroups assigned to �is-
tological grades and TN� stages �data not s�own�.
To c�eck w�et�er DNA repair gene polymorp�isms 
were associated wit� tobacco smoking� participants 
were categorized into groups according to smoking 
�abits �Table�. T�ere were no significant differences 
inside t�ese groups in t�e Arg�99Gln and Arg4��Gln 
polymorp�isms genotypes distribution �p > �.���. Ad-
ditionally� we did not find any association of investigated 
polymorp�isms and drinking status �Table�. We did not 
find any association of drinking and smoking status and 
laryngeal cancer for carriers of bot� variant genotypes 
of XRCC1 and ERCC4 genes �data not s�own�.
Our results indicated t�at Arg�99Gln polymor-
p�ism of XRCC1 gene and Arg4��Gln polymorp�ism 
of ERCC4 gene may not be associated wit� smoking- 
and drinking-related larynx cancer in Polis� population.
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Table. Genotype distribution and odds ratio (OR) for Arg399Gln polymorphism of XRCC1 gene and Arg415Gln polymorphism of ERCC4 gene for  laryngeal 
cancer patients and controls
Arg399Gln - XRCC1, number of patients/controls Arg415Gln - ERCC4 number of patients/controls
Arg/Arg Arg/Gln Gln/Gln ORa /p Arg/Arg Arg/Gln Gln/Gln ORa /p
smokers
never 12/50 12/56 8/17 1.23/0.30 29/106 2/17 1/0 1.13/0.69
ever 33/30 46/33 22/13 0.83/0.30 88/70 11/6 2/0 1.07/0.80
moderate 17/12 17/15 7/4 0.81/0.30 37/28 4/3 0/0 1.06/0.85
heavy 31/13 36/9 12/1 0.76/0.19 67/20 9/3 3/0 0.98/0.95
drinkers
never 24/45 26/50 10/17 1.32/0.17 55/99 4/13 1/0 1.05/0.88
moderate 54/51 62/55 34/15 0.83/0.30 130/108 16/13 4/0 1.03/0.77
heavy 15/9 23/8 5/3 0.81/0.30 36/17 6/3 1/0 1.09/0.79
Note: a — odds ratio adjusted with age and sex; odds ratio calculated for Arg/Gln + Gln/Gln genotype carriers, Arg/Arg genotype served as the reference (OR = 1.00).
